Skip to main content
. Author manuscript; available in PMC: 2016 Feb 14.
Published in final edited form as: Nanoscale. 2015 Feb 14;7(6):2805–2811. doi: 10.1039/c4nr07102f

Fig. 4.

Fig. 4

Effects of NP formulation of olaparib on in vitro chemosensitivity in human breast cancer cell lines. Survival of Hs578 T (A) and HCC 38 (B) breast cancer cell lines treated with gemcitabine, docetaxel, or etoposide following treatment with saline (black bars), free (light grey bars) or NP olaparib (dark grey bars) was determined using clonogenic survival assays. * indicates significantly less survival (P < 0.05) than control. ** indicates significantly less surival (P < 0.05) than both groups. N = 6–12 per treatment group.